TG Therapeutics
TGTX
63.34
-1.54
-2.37%
TG Therapeutics
US · TGTX
#1638 by market cap
Listed 1970
63.34
-1.54
-2.37%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
Recent news
-
Rating change
H.C. Wainwright Maintains TG Therapeutics(TGTX.US) With Buy Rating, Maintains Target Price $78Market Newswire · 2026/9/22
-
Rating change
J.P. Morgan Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $72Market Newswire · 2026/8/11
-
Rating change
B. Riley Securities Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $86Market Newswire · 2026/9/2
-
TD Cowen Maintains TG Therapeutics(TGTX.US) With Buy Rating, Maintains Target Price $75Market Newswire · 2026/11/10
-
BofA Securities Maintains TG Therapeutics(TGTX.US) With Sell RatingMarket Newswire · 2026/11/11
-
Rating change
H.C. Wainwright Maintains TG Therapeutics(TGTX.US) With Buy Rating, Maintains Target Price $70Market Newswire · 2026/7/6
-
Rating change
H.C. Wainwright Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $78Market Newswire · 2026/8/4
-
Rating change
Jefferies Maintains TG Therapeutics(TGTX.US) With Buy Rating, Maintains Target Price $83Market Newswire · 2026/7/14
-
Rating change
TG Therapeutics (TGTX) Gets a Buy From H.C. WainwrightTipRanks · 2026/7/13
-
Evercore Initiates TG Therapeutics(TGTX.US) With Buy Rating, Announces Target Price $71Market Newswire · 2026/11/10
-
Rating change
BofA Securities Maintains TG Therapeutics(TGTX.US) With Sell Rating, Raises Target Price to $21Market Newswire · 2026/8/5
-
Rating change
TD Cowen Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $75Market Newswire · 2026/7/22
-
J.P. Morgan Maintains TG Therapeutics(TGTX.US) With Buy RatingMarket Newswire · 2026/10/27
-
Rating change
TG Therapeutics (TGTX) Receives a Buy From H.C. WainwrightTipRanks · 2026/9/22
-
Rating change
Jefferies Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $83Market Newswire · 2026/6/23
-
Rating change
B. Riley Securities Remains a Buy on TG Therapeutics (TGTX)TipRanks · 2026/9/2
-
J.P. Morgan Maintains TG Therapeutics(TGTX.US) With Buy Rating, Announces Target Price $72Market Newswire · 2026/11/10
-
Rating change
BofA Securities Maintains TG Therapeutics(TGTX.US) With Sell Rating, Raises Target Price to $20Market Newswire · 2026/7/7
-
Rating change
H.C. Wainwright Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $77Market Newswire · 2026/7/13
-
Rating change
J.P. Morgan Maintains TG Therapeutics(TGTX.US) With Buy Rating, Announces Target Price $65Market Newswire · 2026/7/16
-
Rating change
TD Cowen Maintains TG Therapeutics(TGTX.US) With Buy Rating, Maintains Target Price $75Market Newswire · 2026/8/4
-
Rating change
Goldman Sachs Maintains TG Therapeutics(TGTX.US) With Hold Rating, Raises Target Price to $41Market Newswire · 2026/5/28
-
Rating change
BofA Securities Maintains TG Therapeutics(TGTX.US) With Sell Rating, Raises Target Price to $17Market Newswire · 2026/6/4
-
Rating change
Goldman Sachs Maintains TG Therapeutics(TGTX.US) With Hold Rating, Maintains Target Price $41Market Newswire · 2026/6/4
-
Rating change
J.P. Morgan Maintains TG Therapeutics(TGTX.US) With Buy RatingMarket Newswire · 2026/5/28
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 20:02:20 · For reference only, not investment advice and not tailored to your situation.
TG Therapeutics discussion 0 comments